U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279714) titled 'Fisetin in Mild Alzheimer's Disease' on Nov. 17.
Brief Summary: This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Alzheimer s Disease
Alzheimer Dementia
Alzheimer Dementia (AD)
Alzheimer Disease
Mild Cognitive Disorder
Neurocognitive Disorders, Mild
Neurocognitive Disorder
Intervention:
OTHER: Fisetin
Fisetin 20mg/kg/day
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sunnybrook Health Sciences Centre
Published by HT Digital ...